Streamlining Home Infusion Prior Auth for Complex Therapies
Klivira automates the complex home infusion prior auth process, ensuring timely approvals for critical therapies like biologics, TPN, and specialized antibiotics.
Home infusion therapy (HIT) represents a critical yet administratively intensive segment of healthcare, where prior authorization delays directly impact patient care continuity and revenue cycles. The intricate requirements for high-cost biologics, total parenteral nutrition (TPN), and extended antibiotic regimens demand a robust, automated solution to mitigate denials and reduce staff burden.
The Unique Challenges of Home Infusion Prior Auth
Prior authorization for home infusion therapies is characterized by high-touch workflows, frequent re-authorizations, and payer-specific clinical documentation requirements. These complexities, coupled with the urgent nature of many infusion treatments, often lead to manual bottlenecks, delayed care, and increased administrative costs for your revenue cycle teams.
Klivira's Solution for Home Infusion Authorization
- Automated submission of X12 278 and payer portal requests for initial and concurrent home infusion authorizations.
- Intelligent data extraction from EMRs (e.g., Epic, Cerner) to populate authorization forms via SMART on FHIR integration.
- Proactive identification of re-authorization needs for long-term therapies like TPN and certain biologics.
- Streamlined coordination with specialty pharmacies for necessary clinical documentation and order fulfillment.
- Real-time status tracking and alerts for all home infusion prior authorization requests, reducing manual follow-up.
- Support for diverse home infusion workflows, including specialty pharmacy coordination and complex therapy management.
Accelerating Patient Access to Critical Therapies
By automating the home infusion prior auth workflow, Klivira significantly reduces turnaround times and denial rates. This ensures patients receive their vital biologics, antibiotics, or TPN without unnecessary delays, improving clinical outcomes and patient satisfaction while optimizing your operational efficiency.
Integration and Compliance Considerations
Klivira integrates seamlessly with leading EMR systems and payer portals, leveraging industry standards like Da Vinci PAS and NCPDP SCRIPT for electronic prior authorization (ePA). Our platform is designed with robust security protocols to protect PHI, aligning with HIPAA regulations. We recommend discussing specific integration and data governance with your IT and compliance teams.
Beyond Automation: Strategic Operational Impact
Implementing Klivira transforms your home infusion prior authorization process from a cost center into a strategically managed workflow. Our analytics provide insights into common denial reasons and payer trends, enabling your team to proactively address issues and improve first-pass approval rates for all home infusion services.
Frequently asked questions
How does Klivira handle payer-specific requirements for home infusion prior auth?
Klivira's platform leverages AI and machine learning to adapt to the nuanced, payer-specific clinical guidelines and submission requirements for home infusion therapies. Our system dynamically populates forms and gathers necessary documentation, minimizing manual adjustments and ensuring compliance with individual payer rules.
Can Klivira integrate with our existing EMR for home infusion orders?
Yes, Klivira offers robust integration capabilities with major EMR systems, including Epic and Cerner, utilizing SMART on FHIR standards. This allows for seamless data exchange, pulling relevant patient and order information directly from the EMR to initiate and complete home infusion prior authorization requests without redundant data entry.
What types of home infusion therapies does Klivira support for prior authorization?
Klivira supports a comprehensive range of home infusion therapies requiring prior authorization, including high-cost biologics, total parenteral nutrition (TPN), specialized antibiotics, inotropic therapies, and other complex intravenous medications. Our platform is designed to manage the diverse documentation and re-authorization schedules associated with these treatments.
How does Klivira improve turnaround times for home infusion prior authorizations?
By automating submission via X12 278 and direct payer portals, streamlining documentation gathering, and providing real-time status tracking, Klivira significantly reduces the administrative burden and manual delays inherent in home infusion prior authorization. This accelerates the approval process, ensuring patients receive timely access to their critical therapies.
Does Klivira assist with re-authorizations for long-term home infusion patients?
Absolutely. Klivira proactively monitors authorization expiration dates for long-term home infusion therapies. Our system can initiate re-authorization workflows automatically, prompting for updated clinical information and submitting renewal requests well in advance, preventing lapses in coverage and ensuring continuity of care.
Related coverage
Ready to ship this workflow?
See how Klivira automates prior authorizations for your team.
Request a demo